Ashland Global (ASH)
NYSEMaterialsChemicals - SpecialtySnapshot 2026-11-05
$76.28-0.21%
Close 2026-11-05 · 1-day change
NYSEMaterialsChemicals - SpecialtySnapshot 2026-11-05
QuarterlyIQ Insights · ASH
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 13.4% |
| Our one-year growth estimate | diamond | 4.6% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-11-05.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 8.8 percentage points more one-year growth.
The one-year revenue growth assumption on Valuation.
Worth watching into the next print: this name is on a run of consecutive earnings misses and has been missing across recent quarters. A fundamental tilt, not a price call.
Model as of 2026-11-05 · Compared with 32 industry peers · Company calendar date is not available
ASH — earnings miss
Dated 2026-11-03
Results of Operations and Financial Condition. On November 3, 2026, Ashland Inc. (“Ashland”) announced preliminary fourth quarter and fiscal year 2026 results and fiscal year 2027 outlook results, which are discussed in more detail in the news release (the “News Release”) attached to this Current Report on Form 8-K (“Form 8-K”) as Exhibit 99.1, which is incorporated herein by reference into this
Why it matters: Meeting this revenue target would prove that management's growth plan is working.
Supportive ifFiscal 2026 revenue reported at or above $1,835 million.
Worry ifFiscal 2026 revenue is below $1,835 million. This shows possible issues in execution.
Why it matters: Ashland reaffirmed fiscal 2026 sales guidance of $1.835 billion to $1.870 billion. Meeting that range would back its growth plan.
Supportive ifOn Nov. 3, Ashland keeps fiscal 2026 sales guidance at $1.835 billion to $1.870 billion and reports sales that support the range.
Worry ifAshland cuts fiscal 2026 sales guidance below $1.835 billion or reports sales that no longer support the range.
Why it matters: The sector report says Materials revenue is shrinking, but recent data hints that the decline may be easing. Positive growth would support demand for Ashland's products.
Watch forThe sector data shows Materials revenue growth above 0%.
Also watch forThe sector data keeps Materials revenue growth below 0%, with no reported turn to growth.
Why it matters: Keeping cash flow strong is important. It helps with finances and spending.
Supportive ifFree Cash Flow was above $15 million in Q3. This supports the target.
Worry ifOngoing Free Cash Flow drops below $10 million in Q3, indicating potential issues.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$86 on $10,000 · ±0.9% | How much price usually moves either way. |
| Bad day | $296 loss on $10,000 · 3.0% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $2,417 loss on $10,000 · 24.2% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: Strong cash flow conversion shows good money management. It also shows efficiency.
Supportive ifOngoing Free Cash Flow conversion rates stay above 50% in Q4.
Worry ifConversion rates are below 50%. This shows cash flow problems.
Why it matters: Lower cash flow may show worse efficiency and financial health.
Worry ifCash flow from operations was below $50 million.
Less concerning ifCash flow from operations reported at or above $50 million.
Why it matters: Ashland reaffirmed this sales range after Q3 sales rose 7%. A miss would break its stated growth goal.
Worry ifFiscal 2026 sales finish below $1,835 million, the low end of the reaffirmed range.
Less concerning ifFiscal 2026 sales finish at or above $1,835 million.
Why it matters: A successful increase is key for stable operations. It can help make more money.
Watch forManagement says the ramp-up is going well. Productivity is better at the Hopewell site.
Also watch forThere are still delays in the ramp-up at the Hopewell facility.
Why it matters: Strong sales growth shows management is doing well. It helps meet revenue goals.
Supportive ifQ3 sales growth was above 7% compared to last year.
Worry ifQ3 sales growth was below 5% compared to last year.
Why it matters: This shows ongoing problems. It may affect future growth.
Worry ifQ3 Adjusted EBITDA was less than $385 million.
Less concerning ifQ3 Adjusted EBITDA was more than $400 million.
Why it matters: Updates will show how Ashland deals with global risks that affect its work.
Watch forGood updates on supply chain strength and customer service.
Also watch forBad updates show supply chain problems or lower service levels.
Why it matters: Hitting this target is key for making more money and cash flow. It shows efficiency.
Supportive ifAdjusted EBITDA is $385 million. This shows recovery from past problems.
Worry ifAdjusted EBITDA is below $385 million. This shows ongoing issues and cost pressures.
Why it matters: Meeting this sales target shows Ashland is on track with its growth goals. It confirms strong demand across business units.
Supportive ifQ4 sales reach or exceed $1,835 million, confirming growth strategy success.
Worry ifQ4 sales drop below $1,835 million. This shows possible demand problems.
Why it matters: Hitting this target would show strong demand. It would also show good execution.
Supportive ifQ3 revenue reported between $1,835 million and $1,870 million.
Worry ifQ3 revenue reported below $1,835 million.
Why it matters: New board members may bring new ideas that improve strategy and governance.
Supportive ifPublic statements or reports show contributions from new board members.
Worry ifNo important changes in board dynamics are reported.
Why it matters: Meeting this target would show better profits. It would also improve operations.
Supportive ifAdjusted EBITDA for Q3 is over $109 million. This shows strong recovery in operations.
Worry ifAdjusted EBITDA is below $109 million. This shows there are ongoing problems.
Why it matters: New directors and a new committee will review capital use and planning. A clear plan would show how the board acts on that work.
Watch forAshland shares a clear plan for how it will use capital. Steps may include cutting debt, investing, or returning cash.
Also watch forAshland gives no clear capital allocation plan or steps in its next results or SEC filing.
Why it matters: New directors may help improve decisions and how the company runs.
Supportive ifThere are positive changes in governance or strategy after new members join.
Worry ifNo clear changes in governance or strategy after new board members join.
Why it matters: Sales growth is key to achieving full-year revenue targets. Meeting this target shows strong demand.
Supportive ifQ3 sales are over $497 million. This shows strong demand in all business units.
Worry ifQ3 sales are under $497 million. This suggests weaker demand and possible challenges.
Why it matters: Growth in Life Sciences helps Ashland's plan. It may also boost overall profits.
Supportive ifLife Sciences sales growth reported above 10% year over year.
Worry ifLife Sciences sales growth reported below 10% year over year.
Why it matters: Weak sales in the Middle East may show wider market problems. This could hurt overall performance.
Worry ifSales from the Middle East fell a lot because of geopolitical tensions.
Less concerning ifSales from the Middle East are steady or increasing. This is true even with tensions.
Why it matters: Ashland tracks a 50% conversion goal and reported strong Q3 cash flow. A lower year-end rate would weaken that progress.
Worry ifFiscal 2026 ongoing free cash flow is less than 50% of Adjusted EBITDA.
Less concerning ifFiscal 2026 ongoing free cash flow is at least 50% of Adjusted EBITDA.
Why it matters: Success in these strategies will drive growth in key segments like Life Sciences and Personal Care.
Supportive ifContinued sales growth in Life Sciences and Personal Care segments.
Worry ifSales do not grow or fall in these segments. This shows a failed strategy.